Among active 13F managers last quarter, 5 opened and 16 added, while 11 reduced; the largest holder to move was Timothy G. Youngquist 2020 Irrevocable Trust (+6.2%). No open-market insider trades in the last 180 days.
Funds lean in and no leg opposes.
138 tracked 13F filers disclose a position in CHRS as of the latest SEC 13F filings, a combined $92.5M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Shares | Position value | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | Timothy G. Youngquist 2020 Irrevocable Trust | 13.1M | $18.3M | ▲+6.2% Added · +760K sh | Q2 2026 | |
| 2 | BlackRock, Inc. | 12.0M | $16.8M | ▲+16% Added · +1.6M sh | Q2 2026 | |
| 3 | Vanguard Capital Management LLC | 5.9M | $8.3M | ▲+9.1% Added · +497K sh | Q2 2026 | |
| 4 | Geode Capital Management, LLC | 3.7M | $5.2M | ▲+18% Added · +564K sh | Q2 2026 | |
| 5 | Samsara BioCapital, LLC | 3.4M | $4.8M | —Held | Q2 2026 | |
| 6 | State Street Corp | 2.4M | $3.3M | ▲+2.4% Added · +56K sh | Q2 2026 | |
| 7 | Two Sigma Investments, LP | 2.3M | $3.9M | ▲+357% Added · +1.8M sh | Q1 2026 | |
| 8 | CM Management, LLC | 2.1M | $2.9M | —Held | Q2 2026 | |
| 9 | Alyeska Investment Group, L.P. | 1.7M | $2.4M | ▼−23% Reduced · −517K sh | Q2 2026 | |
| 10 | Hudson Bay Capital Management LP | 1.7M | $2.4M | ▼−0.7% Reduced · −12K sh | Q2 2026 | |
| 11 | AQR Capital Management LLC | 1.2M | $2.0M | ▲+36% Added · +320K sh | Q1 2026 | |
| 12 | Charles Schwab Investment Management Inc | 1.2M | $2.0M | ▲+24% Added · +221K sh | Q1 2026 | |
| 13 | Panagora Asset Management Inc | 1.1M | $1.6M | ▼−22% Reduced · −322K sh | Q2 2026 | |
| 14 | Vanguard Fiduciary Trust Co | 1.0M | $1.4M | ▲+7.0% Added · +66K sh | Q2 2026 | |
| 15 | Northern Trust Corp | 914K | $1.5M | ▲+15% Added · +120K sh | Q1 2026 | |
| 16 | Vanguard Portfolio Management LLC | 883K | $1.2M | ▲+46% Added · +279K sh | Q2 2026 | |
| 17 | Goldman Sachs Group Inc | 696K | $1.2M | ▲+127% Added · +389K sh | Q1 2026 | |
| 18 | UBS Group AG | 547K | $925K | ▼−10% Reduced · −64K sh | Q1 2026 | |
| 19 | Sei Investments Co | 454K | $767K | ▲+492% Added · +377K sh | Q1 2026 | |
| 20 | Bridgeway Capital Management, LLC | 391K | $547K | ▼−11% Reduced · −50K sh | Q2 2026 | |
| 21 | Renaissance Technologies LLC | 332K | $561K | ▲+141% Added · +194K sh | Q1 2026 | |
| 22 | Bank Of America Corp | 324K | $548K | ▲+190% Added · +212K sh | Q1 2026 | |
| 23 | STRS Ohio | 324K | $548K | —Held | Q1 2026 | |
| 24 | Millennium Management LLC | 312K | $527K | ▼−53% Reduced · −348K sh | Q1 2026 | |
| 25 | Susquehanna International Group, LLP | 288K | $486K | ▼−25% Reduced · −95K sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 5 funds opened a new position in CHRS and 16 added to an existing one, while 11 reduced. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Their position there |
|---|---|---|
| Nvidia CorpNVDA | 60 funds | $184.1B |
| Amazon.com IncAMZN | 60 funds | $86.9B |
| Microsoft CorpMSFT | 59 funds | $106.5B |
| Alphabet Inc-CL AGOOGL | 59 funds | $80.5B |
| Broadcom IncAVGO | 59 funds | $74.6B |
| Eli Lilly & CoLLY | 59 funds | $40.0B |
| Advanced Micro DevicesAMD | 59 funds | $31.4B |
| Netflix IncNFLX | 58 funds | $20.2B |
| Apple IncAAPL | 57 funds | $129.4B |
| Meta Platforms Inc-Class AMETA | 57 funds | $50.5B |
| Tesla IncTSLA | 57 funds | $31.7B |
| Visa Inc-Class A SharesV | 57 funds | $28.6B |
Ranked by how many of CHRS's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in CHRS.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| May 23, 2025 | Wahlstrom Mats | Director | Sell (S) | 100K | $74K |
| Nov 22, 2023 | Lanfear Dennis M | President & CEO, Director | Sell (S) | 223K | $451K |
| Oct 15, 2021 | Stilwell McDavid | Chief Financial Officer | Sell (S) | 4K | $59K |
| Sep 29, 2021 | Healy James | Director | Sell (S) | 286K | $4.6M |
| Sep 28, 2021 | Healy James | Director | Sell (S) | 48K | $830K |
| Sep 27, 2021 | Healy James | Director | Sell (S) | 100K | $1.8M |
| Jun 9, 2021 | Stilwell McDavid | Chief Financial Officer | Buy (P) | 4K | $50K |
| Jun 8, 2021 | Lanfear Dennis M | President & CEO, Director | Sell (S) | 31K | $421K |
| Mar 9, 2021 | Vexler Vladimir | Chief Scientific Officer | Sell (S) | 114K | $1.9M |
| Mar 5, 2021 | Anicetti Vincent R | Chief Operating Officer | Sell (S) 2 lots, same day | 27K | $412K |
| Feb 17, 2021 | Anicetti Vincent R | Chief Operating Officer | Sell (S) | 2K | $43K |
| Feb 1, 2021 | Viret Jean-Frederic | Chief Financial Officer | Sell (S) | 7K | $160K |
One row per insider, day and transaction code; shares and value are summed across the lots. Every lot is on the full insider page and in the filing.
Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.
Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive
| Source | Buying | Selling | Net |
|---|---|---|---|
13F funds Top 100 holders by value, passive included; the hero counts active managers only | 37 | 27 | – |
Insiders Form 4 open-market | 0 | 0 | $0 |
US House STOCK Act trades | 0 | 0 | $0 |
Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.
Connected entities for CHRS
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/CHRS/capital-change-brief"
Use Arkolith's capital_change_brief for CHRS. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for CHRS. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.